Influence of interleukin-1β gene polymorphisms on age-at-onset of sporadic Parkinson's disease

Neuroscience Letters

Volumn 284, Issue 1-2, 2000, Pages 73-76

  Nishimura, Masataka ^a   Mizuta, Ikuko ^a   Mizuta, Eiji ^a   Yamasaki, Shunzou ^a   Ohta, Mitsuhiro ^a   Kuno, Sadako ^a  

^a UTANO NATIONAL HOSPITAL   (Japan)

Author keywords

Interleukin 1 ; Interleukin 1 receptor antagonist; Interleukin 1 ; Parkinson's disease; Polymorphism

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 1;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PRIORITY JOURNAL; PROMOTER REGION; AGE; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; JAPAN; MALE; MIDDLE AGED; RISK FACTOR;

AGE FACTORS; AGED; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-1; JAPAN; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0034696701     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)00991-5     Document Type: Article

References (17)

1. Blum-Degen D., Muller T., Kuhn W., Gerlach M., Przuntek H., Riederer P. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett. 202:1995;17-20.
2. Breitner J.C. Inflammatory processes and anti- inflammatory drugs in Alzheimer's disease: a current appraisal. Neurobiol. Aging. 17:1996;789-794.
3. Calne D.B., Snow B.J., Lee C. Criteria for diagnosing Parkinson's disease. Ann. Neurol. 32:1992;S125-S127.
4. Ebadi M., Srinivasan S.K., Baxi M.D. Oxidative stress and antioxidant therapy in Parkinson's disease. Prog. Neurobiol. 48:1996;1-19.
5. Ma J.J., Nishimura M., Mine H., Kuroki S., Nukina M., Ohta M., Saji H., Obayashi H., Saida T., Kawakami H., Uchiyama T. HLA and T-cell receptor gene polymorphisms in Guillain-Barré syndrome. Neurology. 51:1998;379-384.
6. Mansfield J.C., Holden H., Tarlow J.K., di Giovine F.S., McDowell T.L., Wilson A.G., Holdsworth C.D. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology. 106:1994;637-642.
7. McDowell T.L., Symons J.A., Ploski R., Førre Ø., Duff G.W. A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1α polymorphism. Arthritis. Rheum. 38:1995;221-228.
8. Mogi M., Harada M., Kondo T., Riederer P., Inagaki H., Minami M., Nagatsu T. Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci. Lett. 180:1994;147-150.
9. Nemetz A., Nosti-Escanilla M.P., Molnár T., Köpe A., Kovács A., Fehér J., Tulassay Z., Nagy F., García-González M.A., Pena A.S. IL-1B gene polymorphisms influence the course and severity of inflammatory bowel disease. Immunogenetics. 49:1999;527-531.
10. Papassotiropoulos A., Bagli M., Jessen F., Bayer T.A., Maier W., Rao M.L., Heun R. A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease. Ann. Neurol. 45:1999;666-668.
11. Pociot F., Mølvig J., Wogensen L., Worsaae H., Nerup J. A TaqI polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro. Eur. J. Clin. Invest. 22:1992;396-402.
12. Rothwell N., Allan S., Toulmond S. Perspective series: cytokines and the brain. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J. Clin. Invest. 100:1997;2648-2652.
13. Santtila S., Savinainen K., Hurme M. Presence of the IL-1RA alle 2 (IL1RN*2) is associated with enhanced IL-1β production in vitro. Scand. J. Immunol. 47:1998;195-198.
14. Schapira A.H.V., Cooper J.M., Dexter D. Mitochondrial complex I deficiency in Parkinson's disease. Lancet. 1:1989;1269.
15. Schrijver H.M., Crusius J.B.A., Uitdehaag B.M.J., González G., Kostense P.J., Polman C.H., Pena A.S. Association of interleukin-1β and interleukin-1 receptor antagonist genes with disease severity in MS. Neurology. 52:1999;595-599.
16. Wang J., Bankiewicz K.S., Plunkett R.J., Oldfield E.H. Intrastriatal implantation of interleukin-1: reduction of parkinsonism in rats by enhancing neuronal sprouting from residual dopaminergic neurons in the ventral tegmental area of the midbrain. J. Neurosurg. 80:1994;484-490.
17. Wilkinson R.J., Patel P., Llewelyn M., Hirsch C.S., Pasvol G., Snounou G., Davidson R.N., Toossi Z. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1β on tuberculosis. J. Exp. Med. 189:1999;1863-1873.